Trials / Unknown
UnknownNCT05959954
Predicting Nociplastic Pain in Carpal Tunnel Syndrome Through Quantitative Sensory Testing
Quantitative Sensory Testing to Predict Progression to Nociplastic Pain in Carpal Tunnel Syndrome: A Prospective Cohort Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- Ahram Canadian University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to investigate the predictive value of quantitative sensory testing (QST) in identifying patients with carpal tunnel syndrome (CTS) who are at risk of developing nociplastic pain.
Detailed description
The study will recruit 120 adults diagnosed with CTS and conduct baseline QST measures. The progression to nociplastic pain will be assessed over a one-year follow-up period to determine the predictive value of QST measures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Quantitative Sensory Testing (QST) | Quantitative Sensory Testing (QST) is a non-invasive diagnostic method used to assess sensory dysfunction. The test evaluates individual thresholds and pain responses to different types of mechanical, thermal, and electrical stimuli. For this study, QST will be used to gather baseline sensory data for patients with carpal tunnel syndrome. This information will then be used to predict the progression to nociplastic pain over a one-year follow-up period. |
Timeline
- Start date
- 2023-07-21
- Primary completion
- 2024-07-21
- Completion
- 2024-11-30
- First posted
- 2023-07-25
- Last updated
- 2023-07-25
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05959954. Inclusion in this directory is not an endorsement.